Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran.
Department of Health, Nutrition & Infectious Diseases, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.
J Environ Public Health. 2021 Oct 22;2021:9081491. doi: 10.1155/2021/9081491. eCollection 2021.
This study was conducted to evaluate the anti-SARS-CoV-2 IgM and IgG antibodies among healthcare workers in Guilan.
This cross-sectional study was conducted on 503 healthcare workers. Between April and May 2020, blood samples were collected from the healthcare workers of Razi Hospital in Rasht, Guilan, Iran. Enzyme-linked immunosorbent assay (ELISA) was used for the detection and quantitation of anti-SARS-CoV-2 IgM/IgG antibodies by using kits made by Pishtaz Teb Company, Tehran, Iran.
From a total of 503 participants, the result of the anti-SARS-CoV-2 IgM antibody test was positive in 28 subjects (5.6%) and the anti-SARS-CoV-2 IgG antibody test was positive in171 subjects (34%). Participants in the age group of 35-54 years were significantly more likely to have a positive anti-SARS-CoV-2 antibody test than the age group of 20-34 years (odds ratio = 1.53, 95% CI: 1.04-2.25, =0.029). Also, physicians were significantly more likely to have a positive antibody test than office workers (odds ratio = 1.92, 95% CI: 1.04-3.54, =0.037). The wide range of symptoms was significantly associated with the positive anti-SARS-CoV-2 antibody test. The most significant association was observed between fever and a positive anti-SARS-CoV-2 antibody test (odds ratio = 3.03, 95% CI: 2.06-4.44, < 0.001).
The results of the current study indicated that the seroprevalence of COVID-19 was high among healthcare workers of Guilan Province. It seems that this finding was due to the earlier exposure to COVID-19 and the lack of awareness and preparedness to deal with the pandemic in Iran, compared to other countries.
本研究旨在评估伊朗吉兰省医护人员的 SARS-CoV-2 IgM 和 IgG 抗体。
这是一项横断面研究,共纳入 503 名医护人员。2020 年 4 月至 5 月,采集来自伊朗拉什特拉扎医院的医护人员血样。采用酶联免疫吸附试验(ELISA),使用由伊朗德黑兰皮什塔兹泰布公司生产的试剂盒检测并定量 SARS-CoV-2 IgM/IgG 抗体。
在总共 503 名参与者中,28 名(5.6%)的 SARS-CoV-2 IgM 抗体检测结果为阳性,171 名(34%)的 SARS-CoV-2 IgG 抗体检测结果为阳性。与 20-34 岁年龄组相比,35-54 岁年龄组的参与者更有可能 SARS-CoV-2 抗体检测呈阳性(比值比=1.53,95%可信区间:1.04-2.25,=0.029)。此外,与办公室工作人员相比,医生更有可能 SARS-CoV-2 抗体检测呈阳性(比值比=1.92,95%可信区间:1.04-3.54,=0.037)。广泛的症状与 SARS-CoV-2 抗体检测呈阳性显著相关。观察到的最显著相关性是发热与 SARS-CoV-2 抗体检测呈阳性之间的相关性(比值比=3.03,95%可信区间:2.06-4.44, < 0.001)。
本研究结果表明,吉兰省医护人员 COVID-19 的血清流行率较高。与其他国家相比,伊朗可能更早地接触到 COVID-19,并且在应对大流行方面缺乏意识和准备,这可能是造成这种发现的原因。